This Friday is #WorldPrematurityDay. Let's spotlight the resilience of premature babies and acknowledge the dedicated efforts of medical professionals in neonatal care. Together, we can make a difference for the 15 billion babies born too soon every year. simedx.com/world-prematurity…
This Thursday SIME CEO Povl Verder will present at the @flowwVC Investor Showcase. What is Floww? It’s an all-in-one platform fundraising platform that connects founders, venture capitalists and investors through data-centric networking.
#flowwio #seriesA #medtechinvestment
Thank you to the Department of Business and Trade for inviting SIME CEO, Povl Verder, to pitch to a captive audience of lifesciences investors on the London Eye @LDNTechWeek #LondonTechWeek
The SIME team were honoured meet the prestigious Prof Tsu Fuh Yeh last week @PASMeeting . Prof Yeh presented exciting new data about surfactant and budesonide treatment for neonatal CLD/BPD.
SIME scientific co-founder Prof Henrik Verder and Peter Schousbe, SIME Head of R&D, with our esteemed partners @InspHealthcare and @DrRamanathanUSC at last weeks @PASMeeting in Washington.
We will be sharing exciting new data @PASMeeting this week. In continued preparation for market entry, we will also be meeting with our US clinical & commercial partners as well as exploring new opportunities. Interested in meeting us for a chat? Send us a DM. See you there!
Yesterday our CEO had the honour of meeting @Jeremy_Hunt and life sciences leaders to discuss the future of life science innovation in the UK. Thank you @hmtreasury @scale_space and @imperialcollege for hosting us.
xitter.cf/i/broadcasts/1mrxmkZnX…
SIME Diagnostics retweeted
Preterm birth & stillbirth rates during COVID-19 lockdown- analysis of 52 million births! Collaborative led by @MeghanAzad published in Nature Human Behaviour. nature.com/articles/s41562-0…
Irish contribution from UMHL & INHA. @IrishNeonatal
@ULHospitals @UL @MedicineAtUL @RCPI_news
NEW PRESS RELEASE: SIME begins clinical trial validating point-of-care device that rapidly predicts neonatal respiratory disease at birth in the NICU #PressRelease #NICU #respiratory #medicalnews #MEDTECH
prnewswire.co.uk/news-releas…
SIME Diagnostics retweeted
Join us in welcoming new #BIAmember @simedx 💡
They are a clinical AI company with a patented point-of-care platform for rapid prediction of respiratory disease in the ICU.
Find out more 👇
ow.ly/n22750MrsJ2
SIME will be attending the #JPM2023 next week in San Francisco. We will be presenting in-person and online on Monday the 9th at 9:00am PST at the Hilton (Franciscan D - Ballroom Level). Message us for meeting appointments.
#biotech #biotechshowcase #jpm2023
Today is #WorldPrematurityDay2022 - to help raise awareness of the challenges and burden of preterm birth globally we have created an infographic. Please share to highlight the challenges these newborns must overcome to survive & thrive. View infographic: simedx.com/world-prematurity…
SIME Diagnostics retweeted
.@simedx has announced the successful CE-IVD accreditation of the world’s first Clinical AI Platform for the rapid prediction of severe respiratory disease ow.ly/gZ3F50LFLsu
SIME Diagnostics retweeted
more #regulatory wins
~#GenesisMedTechGroup recieves #fda approval Chocolate Touch® Drug-coated Balloon PTA #catheter
~@PerkinElmer nabs clearance for #molecular SCID/SMA test in newborns
~@simedx's clinical #AI platform for severe #respiratorydisease receives CE-IVD mark
ALT Image Source: https://www.med-technews.com/news/Medtech-Diagnostics-news/clinical-ai-platform-for-severe-respiratory-disease-receives/
Our AI device that predicts acute respiratory disease has received a CE Mark - taking us one step closer to changing the standard of care for millions of babies worldwide. Our point-of-care device is now available for investigational use in the NICU. prnewswire.co.uk/news-releas…
SIME Diagnostics retweeted
Clinical AI Platform for severe respiratory disease receives CE-IVD mark
med-technews.com/news/Medtec…
@simedx
#medtech #AI #respiratorydisease #diagnostics
SIME Diagnostics retweeted
SIME bags CE mark for AI device that predicts acute respiratory disease firstwordhealthtech.com/stor… #AI #IVD #digitalhealth #healthtech .@simedx #innovation #approval
Our CEO Povl Verder will be attending @LSXLeaders Inv€$tival Showcase on Monday. Get in touch if you are attending and would like to connect.
SIME STRENGTHENS BOARD TO PREPARE FOR COMMERCIALISATION
Morten Henneveld, a life science executive with decades of commercial and operations experience, joins SIME board as company prepares for Clinical AI Platform product launch in 2023.
prnewswire.co.uk/news-releas…
SIME Diagnostics retweeted
That's a wrap!👏
#FIME2022 is over, but we want more #innovations, networking and business deals! 🚀
✔️ 700+ exhibitors
✔️ 125+ countries
✔️ 12,650+ attendees
✔️ 4 conferences
Special thanks to all the #SMEs who represented the #EUeic at the 🇪🇺 Pavilion. Until next time 👋
